Guidant drama keeps building Stock sales by Dollens, others may stoke lawsuits. Analysts say firm will be OK if sale to Johnson & Johnson unravels.
Please enable JavaScript to view this content.
Story Continues Below
Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.